Study of SLC25A48 in COPD
Part of Lungs & breathing clinical trials.
This study measures a protein called SLC25A48 in people with COPD (a lung condition that makes breathing hard) and in healthy people to learn if it plays a role in the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have pre-COPD or COPD (stages I to IV)
- You are a healthy person without any major medical conditions
- You have not had a COPD flare-up needing emergency care or hospital stay in the last 3 months
- You do not have a neuromuscular disease (like muscular dystrophy)
- You are not severely malnourished or underweight, per your doctor's assessment
- You have not been taking folic acid supplements continuously
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how bacteria in your body and other chemicals relate to COPD. It compares people with COPD to healthy smokers to find differences.
This study looks at how the body’s “innate” (first-line) immune system works in people with COPD compared with healthy volunteers. It may help researchers understand COPD inflammation and how immune responses could be targeted in the future.
This study follows people who currently smoke and people who may have newly found COPD (chronic obstructive lung disease) based on breathing test results. It aims to better understand lung disease in real life and what it means for health over time.
This study looks at people who develop COPD (a long-term lung breathing problem) at a younger age and have severe airflow limitation. It may help researchers better understand COPD in early-onset patients and find ways to improve care for this group.
This study looks at different forms of COPD to find better ways to treat them. It may help you understand your own condition and receive more personalized care.
This study looks at signs (biomarkers) and different types of COPD in Chinese people. It aims to better understand COPD and pre-COPD, which may help with future treatments.
Hear when a new Chronic Obstructive Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.